相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Functional Requirement for PAK1 Binding to the KH(2) Domain of the Fragile X Protein-Related FXR1
Evonne Say et al.
MOLECULAR CELL (2010)
Pak protein kinases and their role in cancer
Bettina Dummler et al.
CANCER AND METASTASIS REVIEWS (2009)
Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells
Beatrix Hage et al.
CELL COMMUNICATION AND SIGNALING (2009)
PAK kinase regulates Rac GTPase and is a potential target in human schwannomas
Christine Flaiz et al.
EXPERIMENTAL NEUROLOGY (2009)
Loss of the Tumor Suppressor Gene NF2, Encoding Merlin, Constitutively Activates Integrin-Dependent mTORC1 Signaling
Miguel A. Lopez-Lago et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth
Marianne F. James et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma
Sylwia Ammoun et al.
CANCER RESEARCH (2008)
Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type
Chunling Yi et al.
CANCER RESEARCH (2008)
An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase
Sean W. Deacon et al.
CHEMISTRY & BIOLOGY (2008)
PAK is required for the disruption of E-cadherin adhesion by the small GTPase Rac
Encarnacion Lozano et al.
JOURNAL OF CELL SCIENCE (2008)
Targeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium Complexes
Jasna Maksimoska et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
P21-activated kinase is required for mitotic progression and regulates Plk1
B. Maroto et al.
ONCOGENE (2008)
MEK/ERK regulates adherens junctions and migration through Rac1
Ramesh M. Ray et al.
CELL MOTILITY AND THE CYTOSKELETON (2007)
The Nf2 tumor suppressor reulates cell-cell adhesion during tissue fusion
Margaret E. McLaughlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac
Helen Morrison et al.
CANCER RESEARCH (2007)
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase
Hongchuan Jin et al.
NATURE (2006)
Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein
DN Chadee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
LX Zhao et al.
NATURE NEUROSCIENCE (2006)
Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors
A Beeser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The GIT-associated kinase PAK targets to the centrosome and regulates Aurora-A
ZS Zhao et al.
MOLECULAR CELL (2005)
Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane
T Okada et al.
JOURNAL OF CELL BIOLOGY (2005)
Merlin, the product of the Nf2 tumor suppressor gene, the p21-activated is an inhibitor of kinase, Pak1
JL Kissil et al.
MOLECULAR CELL (2003)
PAKI phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation
JK Slack-Davis et al.
JOURNAL OF CELL BIOLOGY (2003)
Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene
KC Johnson et al.
ONCOGENE (2002)
Rac-PAK signaling stimulates extracellular signal- regulated kinase (ERK) activation by regulating formation of MEKI-ERK complexes
ST Eblen et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A dominant-negative p65 PAK peptide inhibits angiogenesis
WB Kiosses et al.
CIRCULATION RESEARCH (2002)
Structural basis for neurofibromatosis type 2 - Crystal structure of the merlin FERM domain
T Shimizu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization
JL Kissil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human schwannoma cells
AM Bashour et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
p21-activated kinase links Rac/Cdc42 signaling to merlin.
GH Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling
RJ Shaw et al.
DEVELOPMENTAL CELL (2001)
Tumorigenesis in neurofibromatosis: new insights and potential therapies
N Reed et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Neurofibromatosis type 2
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2000)
Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations
RP Stokowski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
